
Medpace Holdings (MEDP) Stock Forecast & Price Target
Medpace Holdings (MEDP) Analyst Ratings
Bulls say
Medpace Holdings is poised for growth, with expectations of passthrough revenues increasing by 200-300 basis points in the second half of the year compared to already elevated levels in the second quarter. The company's strong performance in the first quarter, highlighted by higher request-for-proposals (RFP) volume, suggests a favorable trend in demand for its services. Additionally, Medpace anticipates a return to a book-to-bill ratio exceeding 1.15x in the third quarter, indicating robust business development and a positive outlook for future revenue generation.
Bears say
Medpace Holdings has faced significant challenges, evidenced by a persistent level of backlog cancellations that remain at or above the upper range of what the company deems normal, although they recently declined to the lower end of this range in Q2. Furthermore, despite a forecasted adjusted EBITDA growth for 2025 and 2026, the company anticipates continued hiring in direct service costs, which may pressure overall profitability. Additionally, the uncertainty surrounding the expected growth of Direct Service revenue raises concerns over future financial performance, reflecting a cautious outlook moving forward.
This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.
Medpace Holdings (MEDP) Analyst Forecast & Price Prediction
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares